Today, true LMS is immunohistochemically distinguished from other mesenchymal tumors by virtue of the expression of smooth muscle actin (SMA) and desmin, but not GIST markers (KIT, CD34, and DOG1) or the schwannoma marker (S100) [4]. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.